Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06405529

Rehabilitation of Patients From the ICU to the Post-hospital Phase

Introduction: Advances in knowledge have contributed to the increase in the number of patients who survive prolonged hospitalization in an Intensive Care Unit (ICU), and, among them, critically ill patients who develop acute respiratory failure and need for mechanical ventilation. These individuals have their mobility restricted to bed, and may suffer from pulmonary and systemic complications, such as ICU-Acquired Muscle Weakness, which increases the chances of resulting in reduced functional capacity or death. Early mobilization in the ICU has demonstrated benefits, but still with a low level of evidence. However, the type and intensity of exercise still need to be better defined, and previous protocols did not offer continuous monitoring from the ICU to the ward and subsequent outpatient rehabilitation for these patients, which is considered a limitation in some studies.

Objective: To investigate the effects of an early and intensive hospital mobilization and post-hospital rehabilitation program on indicators of functionality, inflammation, cost-effectiveness, and mortality in critically ill patients undergoing invasive mechanical ventilation.

Methods: This is a Blind Randomized Controlled Clinical Trial that will be conducted in the ICUs of the Hospital das Clinicas and the Emergency Unit of the Faculty of Medicine of Ribeirao Preto of the University of São Paulo. Patients of both sexes over 21 years of age who have been under invasive mechanical ventilation for at least 24 hours will be recruited. Patients will be randomized into the Intervention Group (IG), with 30 to 60 minutes of exercise per day, and the Control Group (CG), with 10 minutes of exercise per day, both with the same protocol and based on the ICU Mobility Scale - IMS, with continuity in the ward. After hospital discharge, participants will be allocated to the Guidance Group (GIor and GCor) and the Outpatient Rehabilitation Group (GIreab and GCreab), with functional exercise capacity as the main outcome, assessed by the six-minute walk test (6MWT). Volunteers will be monitored one, three, and six months after hospital discharge. The sample calculation was based on the results of the 6MWT , with a power of 80% for the assessments carried out at the proposing institution (n=206), and with a power of 90% for the multicenter project (n=275), considering a sample loss of 30%. The following will be evaluated: clinical parameters, severity indexes, functionality, lung function and mechanics, functional exercise capacity, mortality, inflammatory markers, energy expenditure, activities of daily living, quality of life, muscle assessment, adherence, barriers and facilitators and cost-effectiveness.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both sexes
  • Age greater than or equal to 21 years
  • Be on invasive mechanical ventilation (IMV) for at least 48 hours
  • Sufficient cardiovascular stability for mobilization
  • Absence of bradyarrhythmia (< 50 bpm);
  • Heart rate ≥ 150 bpm;
  • Most recent lactate measurement ≤ 4.0mmol/L;
  • Combined adrenaline/noradrenaline infusion rate ≤ 0.2mcg/Kg/min, OR if the adrenaline/noradrenaline infusion was increased by more than 25% in the last 6 hours;
  • Cardiac index ≥ 2.0L/min/m2; when evaluated
  • Respiratory stability sufficient for mobilization f) Respiratory rate ≤ 45rpm; g) FiO2 ≤ 0.6; h) PEEP ≤ 16 cmH2O; i) No need for NO (nitric oxide), prone position, neuromuscular blocker, ECMO (extracorporeal membrane oxygenation) or HFOV (high frequency ventilation).

Exclusion criteria

  • Dependent for ADLs in the month prior to ICU admission;
  • Diagnosed cognitive deficit;
  • Diagnosis OR suspicion of acute primary brain disease (TBI, stroke);
  • Diagnosis OR suspected spinal cord injury OR other neuromuscular disease that may result in prolonged or permanent muscle weakness (except muscle weakness acquired in the ICU);
  • Need OR instructions to remain in bed OR not to bear weight on the lower limbs bilaterally;
  • Life expectancy of less than 180 days due to acute or chronic clinical conditions;
  • Death considered inevitable due to current clinical condition or if the patient/clinical guardian is not committed to complete active treatment (e.g. brain death);
  • Inability to communicate in Portuguese;
  • Readmission to the ICU of the same hospital service;
  • Pregnant women;
  • Patients with a permanent pacemaker.

Treatment and study plan

Early and intensive mobilization protocol at the ICU and Rehabilitation post-hospital discharge

Other

During hospitalization in the ICU and ward, you will perform 30 to 60 minutes of exercises per day, according to the IMS scale.

After hospital discharge, participation in a supervised exercise program twice a week for 8 weeks at the Rehabilitation Center - CER of the Hospital das Clínicas of the Faculty of Medicine of Ribeirão Preto.

Primary outcomes

  1. Functional exercise capacity

    Time frame: Through study completion, an average of 5 year

    Assessed by the 6-minute walk test

Secondary outcomes

  1. Clinical parameters

    Time frame: Through study completion, an average of 5 year

    Hemodynamic data will be evaluated beafore and after the mobilization protocol

  2. Clinical parameters

    Time frame: Through study completion, an average of 5 year

    Level of sedation evaluated by the Richmond Agitation-Sedation Scale (RASS). The scale ranges from -4 to +5, from the highest level of agitation to coma.

  3. Clinical parameters

    Time frame: Through study completion, an average of 5 year

    Length of stay in the ICU (tICU) and Length of hospital stay (LoS)

  4. Clinical parameters

    Time frame: Through study completion, an average of 5 year

    Time on mechanical ventilation (tMV)

  5. Severity indexes

    Time frame: Through study completion, an average of 5 year

    Acute Physiologic and Chronic Health Evaluation II Score (APACHE II). This tool assesses the severity of the disease and mortality of patients admitted to the ICU, consisting of 12 variables that include: age, past medical history, as well as clinical and physiological indices.

  6. Severity indexes

    Time frame: Through study completion, an average of 5 year

    Sequential Organ Failure Assessment Score (SOFA Score). This tool calculates both the number and severity of organic dysfunction in six organic systems (respiratory, coagulation, hepatic, cardiovascular, renal and neurological).

  7. Pulmonary function

    Time frame: Through study completion, an average of 5 year

    Spirometry will be used as a tool to assess the lung function. The test will be performed by every volunteer and the measurement will be done by guidelines of the Brazilian Society of Pulmonology and Phthisiology for lung function tests.

  8. Pulmonary function

    Time frame: Through study completion, an average of 5 year

    Impulse oscillometry system (IOS). This test will be perfomed to evaluate the resistance of the respiratory system in accordance with that proposed by Oosteveen (2003).

  9. Pulmonary function

    Time frame: Through study completion, an average of 5 year

    Diffusing capacity of the lungs for carbon monoxide (DLCO). This is a pulmonary function test used to assess the lungs' ability to transfer gas from inspired air to the bloodstream. Normal severity slassification is up to 75% of the predicted value.

  10. Pulmonary function

    Time frame: Through study completion, an average of 5 year

    Computed tomography (CT). The high-resolution CT technique with low dose of radiation will be used, without the administration of iodinated contrast medium, scanning the entire chest in the caudocranial direction, with volumetric acquisition of 1 mm in thickness during complete inspiration. Quantitative analysis of HRCT images will be performed using the scientific program Yacta version 2.8 (Heussel et al., 2009).

  11. Mortality

    Time frame: Through study completion, an average of 5 year

  12. Cost-effectiveness

    Time frame: 12 months after study completion

    Economic evaluation - Patient and Institution costs

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Registry information

Official study title

Rehabilitation of Patients Submitted to Mechanical Ventilation, From the ICU to the Post-hospital Phase: Blinded Randomized Controlled Clinical Trial, With Economic and Multicenter Evaluation

Important dates

Study start
2024
Primary completion
2025
Study completion
2027
First posted
May 8, 2024
Registry last updated
May 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.